| RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (NCT03485118) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2016-05-12 |
| Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla (NCT02626520) | Essentia Health | 2016-05-11 |
| MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma (NCT02592551) | Baylor College of Medicine | 2016-05-11 |
| Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015) (NCT02720081) | Merck Sharp & Dohme LLC | 2016-05-11 |
| A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer (NCT02735980) | Eli Lilly and Company | 2016-05-11 |
| A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia (NCT02733042) | Celgene | 2016-05-11 |
| Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer (NCT04694404) | Aiping Zhou | 2016-05-11 |
| Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types (NCT02772276) | MediBeacon | 2016-05-11 |
| Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study (NCT02632747) | Boehringer Ingelheim | 2016-05-10 |
| Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease (NCT02507284) | Azevan Pharmaceuticals | 2016-05-10 |
| Fluorescent Imaging & Methylene Blue: Ureter Study (NCT03177070) | University of Oxford | 2016-05-09 |
| An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer (NCT02750514) | Bristol-Myers Squibb | 2016-05-09 |
| Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia (NCT02677324) | Dana-Farber Cancer Institute | 2016-05-09 |
| Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer (NCT02769962) | National Cancer Institute (NCI) | 2016-05-09 |
| Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis (NCT02778919) | Kissei Pharmaceutical Co., Ltd. | 2016-05-09 |
| Exploratory Study for Allergy Relief Onset (NCT02722083) | Bayer | 2016-05-07 |
| A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS) (NCT02714036) | MediciNova | 2016-05-06 |
| Pembrolizumab and GM-CSF in Biliary Cancer (NCT02703714) | Robin Kate Kelley | 2016-05-06 |
| A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome. (NCT04111341) | Chung Shan Medical University | 2016-05-06 |
| Ceritinib Rare Indications Study in ALK+ Tumors (NCT02465528) | Novartis Pharmaceuticals | 2016-05-06 |
| Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer (NCT02705300) | Vejle Hospital | 2016-05-06 |
| Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma (NCT02658019) | Lynn Feun, MD | 2016-05-06 |
| TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer (NCT02764333) | Memorial Sloan Kettering Cancer Center | 2016-05-06 |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors (NCT02611024) | PharmaMar | 2016-05-06 |
| A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors (NCT04476641) | Sun Yat-sen University | 2016-05-06 |
| Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus (NCT03026478) | Garlapati Komali | 2016-05-06 |
| Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH) (NCT02750618) | Kyowa Kirin, Inc. | 2016-05-05 |
| STOP Heart Disease in Breast Cancer Survivors Trial (NCT02674204) | Cedars-Sinai Medical Center | 2016-05-05 |
| An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies (NCT02712905) | Incyte Corporation | 2016-05-05 |
| Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N) (NCT04439149) | National Cancer Institute (NCI) | 2016-05-05 |
| FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy (NCT02398773) | National Cancer Institute (NCI) | 2016-05-04 |
| Study of MEK162 for Children With Low-Grade Gliomas (NCT02285439) | Children's Hospital Los Angeles | 2016-05-04 |
| Translational Neuropsychopharmacology Research of Nicotine Addiction (NCT02723162) | Medical University of South Carolina | 2016-05-04 |
| Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients (NCT02732938) | Pfizer | 2016-05-04 |
| A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia (NCT02690714) | Prometic Biotherapeutics, Inc. | 2016-05-04 |
| A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease (NCT02726386) | NeuroDerm Ltd. | 2016-05-04 |
| Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035) (NCT02759315) | Merck Sharp & Dohme LLC | 2016-05-03 |
| Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer (NCT02502266) | National Cancer Institute (NCI) | 2016-05-03 |
| Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB (NCT02354014) | Janssen Research & Development, LLC | 2016-05-03 |
| Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options (NCT02650401) | Hoffmann-La Roche | 2016-05-03 |
| Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer (NCT02452008) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-03 |
| Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms (NCT04629885) | PepTonic Medical AB | 2016-05-03 |
| Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial (NCT02561455) | Astellas Pharma Global Development, Inc. | 2016-05-03 |
| MEDI4736 Combinations in Metastatic Renal Cell Carcinoma (NCT02819596) | Queen Mary University of London | 2016-05-03 |
| A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma (NCT02639182) | Astellas Pharma Global Development, Inc. | 2016-05-03 |
| PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases (NCT02649985) | Brigham and Women's Hospital | 2016-05-02 |
| A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis (NCT02759198) | Yuhan Corporation | 2016-05-02 |
| Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02642965) | Children's Oncology Group | 2016-05-02 |
| Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency (NCT02789397) | Medical College of Wisconsin | 2016-05-02 |
| Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time. (NCT03930069) | Zagazig University | 2016-05-02 |
| Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age (NCT02628444) | Sanofi Pasteur, a Sanofi Company | 2016-05-02 |
| Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects (NCT02672280) | South China Research Center for Stem Cell and Regenerative Medicine | 2016-05-01 |
| Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy (NCT02690558) | UNC Lineberger Comprehensive Cancer Center | 2016-05-01 |
| Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) (NCT02538341) | University of Alabama at Birmingham | 2016-05-01 |
| Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents (NCT02714972) | Jaeb Center for Health Research | 2016-05-01 |
| Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. (NCT02662972) | Norwegian University of Science and Technology | 2016-05-01 |
| Dual Treatment With Lithium and Valproate in ALS. (NCT03204500) | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 2016-05-01 |
| Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis (NCT02786017) | Chinese Academy of Sciences | 2016-05-01 |
| Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (NCT02637024) | Ontario Clinical Oncology Group (OCOG) | 2016-05-01 |
| Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) (NCT02768363) | Candel Therapeutics, Inc. | 2016-05-01 |
| TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA (NCT02836340) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-05-01 |
| Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies (NCT03366324) | Wuhan Sian Medical Technology Co., Ltd | 2016-05-01 |
| OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO (NCT02819011) | Bijan Najafi, PhD | 2016-05-01 |
| Studying Complement Inhibition in Complex Cardiac Surgery (NCT02866825) | InflaRx GmbH | 2016-05-01 |
| Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation (NCT02795650) | Hospital Universitario de Fuenlabrada | 2016-05-01 |
| Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy (NCT02662283) | Sun Yat-sen University | 2016-05-01 |
| Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients (NCT02790580) | National University Hospital, Singapore | 2016-05-01 |
| Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience (NCT02745535) | University of Maryland, Baltimore | 2016-05-01 |
| Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer (NCT02716311) | Intergroupe Francophone de Cancerologie Thoracique | 2016-05-01 |
| A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure (NCT02772029) | The First Affiliated Hospital of Zhengzhou University | 2016-05-01 |
| The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes (NCT03426085) | Eastern Virginia Medical School | 2016-05-01 |
| A Study on the Effectiveness of a Nutritional Supplement With Natural Mastiha in Inflammatory Bowel Diseases. (NCT02796339) | Harokopio University | 2016-05-01 |
| Use of Cyclosporin A for the Treatment of Recurrent Miscarriage (NCT02706470) | Fudan University | 2016-05-01 |
| Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars (NCT02546076) | Insel Gruppe AG, University Hospital Bern | 2016-05-01 |
| Effect of ACE Genotype on Cardiovascular Rehabilitation (NCT02845063) | Balgrist University Hospital | 2016-05-01 |
| Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients (NCT02908347) | MetrioPharm AG | 2016-05-01 |
| Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma (NCT02733380) | Henan Cancer Hospital | 2016-05-01 |
| Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI (NCT03774043) | Shirley Ryan AbilityLab | 2016-05-01 |
| Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study (NCT03016715) | Premier Specialists, Australia | 2016-05-01 |
| Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia (NCT02771574) | Tracey McLaughlin | 2016-05-01 |
| Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006) (NCT02878057) | Peking University Cancer Hospital & Institute | 2016-05-01 |
| Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) (NCT02732678) | Assistance Publique Hopitaux De Marseille | 2016-05-01 |
| Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers (NCT02845778) | Khon Kaen University | 2016-05-01 |
| A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (NCT02751996) | F-star Therapeutics, Inc. | 2016-05-01 |
| Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris (NCT02661958) | Sol-Gel Technologies, Ltd. | 2016-05-01 |
| Omental Islet Transplant (NCT02821026) | University of Alberta | 2016-05-01 |
| Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial (NCT02661477) | Turku University Hospital | 2016-05-01 |
| A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck (NCT02775370) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2016-05-01 |
| Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study (NCT02960997) | Stanford University | 2016-05-01 |
| Intralymphatic Immunotherapy in Increasing Doses, Substudy (NCT02975479) | Karolinska Institutet | 2016-05-01 |
| Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder (NCT02877901) | Mansoura University | 2016-05-01 |
| Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease (NCT03019848) | Instituto Nacional de Cardiologia Ignacio Chavez | 2016-05-01 |
| Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients (NCT02766348) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2016-05-01 |
| Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML (NCT02781883) | Bio-Path Holdings, Inc. | 2016-05-01 |
| Optimized tDCS for the Treatment of Migraine (NCT02562222) | Universidade Federal de Pernambuco | 2016-05-01 |
| Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use (NCT02785406) | The University of Texas Health Science Center, Houston | 2016-05-01 |
| Impact of 5% Lidocaine Medicated Plaster on Allodynic Symptoms of Localized Neuropathic Pain After Knee Surgery (NCT02763592) | University Hospital, Clermont-Ferrand | 2016-05-01 |
| Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis (NCT02606032) | Hamilton Health Sciences Corporation | 2016-05-01 |
| A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. (NCT02774200) | Tianjin Medical University Cancer Institute and Hospital | 2016-05-01 |
| Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma (NCT02670616) | Samsung Medical Center | 2016-05-01 |